OMNI Health Media is a leading online provider of Daily Health News. OMNI’s IMM-101 Gemzar News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
A New Drug That 'Wakes Up' Immune System Appears to Fight Pancreatic Cancer

October 4, 2016

A New Drug That ‘Wakes Up’ Immune System Appears to Fight Pancreatic Cancer

By Anonymous User anonymous_user_10987

A novel drug, IMM-101 has extended the lives of some people with metastatic pancreatic cancer and appears to have minimal side-effects. Doctors describe IMM-101 as “waking up” the immune system to attack cancer. Patients who were given the new immunotherapy drug actually felt better than those who were on standard chemotherapy, said Angus Dalgleish, professor […]

View full entry

Tags: gemcitabine, IMM-101 Gemzar, immunotherapy, News Tips and Features, News Tips and Features Other, Pancreatic Cancer

View more articles like this
More news and in-depth Pancreatic Cancer information